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Abstract
A response to Seiler et al: Interrupted or continuous slowly absorbable sutures for closure of primary elective
midline abdominal incisions: a multicenter randomized trial (INSECT: ISRCTN24023541). Ann Surg 2009, 249(4):576-
582.
Background: Existing evidence suggests that the transfer of results of randomized controlled trials into clinical
practice may be limited. Potential reasons can be attributed to aspects of external validity. The aim of this study is
to investigate issues related to the external validity of the INSECT trial.
Methods: All participating surgical departments were categorized and the clinical and baseline characteristics of
randomized patients were evaluated. In addition, demographic and clinical data of all screened and randomized
patients at the Departments of Surgery in Heidelberg and Erlangen were analyzed.
Results: Twenty-five centers enrolled a total of 625 patients. These centers included eight primary, 11 secondary,
and six tertiary care centers. The tertiary care centers enrolled the most patients (n = 237, 38%) followed by the
primary care centers (n = 199, 32%) and the secondary care centers (n = 189 patients; 30%). The mean number
and baseline data of randomized patients did not differ between the three types of care centers (p = 0.09). Overall,
the treatment according to protocol was at least 92%. At the Department of Surgery, University of Heidelberg, 307
patients were screened and 60 out of 130 eligible patients were randomized. There were no differences in
demographic and clinical baseline data between included and non-included patients. In Erlangen, 351 patients
were screened and 57 out of 106 eligible patients randomized.
Conclusions: Results of the INSECT trial are applicable to a broad spectrum of patients treated at different hospital
levels.
Background
Incisional hernias of midline incisions are the most
common long-term complication after major abdominal
surgery with an incidence ranging from 5% - 24% [1].
Although randomized clinical trials (RCTs) and meta-
analyses [2] have been performed in order to define
optimal closure strategies, clinical uncertainty still has
not been resolved.
It has been shown that RCTs have average patient
exclusion rates ranging from 73% to 97% [3]. This
“selection” of patients together with the assumption that
patients enrolled in RCTs receive potentially better
treatment than their non-included counterparts [4] may
weaken the transfer of obtained results into routine
practice. In general, factors which potentially impair the
clinical translation of results achieved in RCTs are sum-
marized under the terms of internal and external
* Correspondence: lars.fischer@med.uni-heidelberg.de
1Department of General, Visceral and Transplantation Surgery, University of
Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany
Full list of author information is available at the end of the article
Fischer et al. BMC Surgery 2012, 12:2
http://www.biomedcentral.com/1471-2482/12/2
© 2012 Fischer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.validity. Internal validity of RCTs focuses on accuracy
and precision in order to minimize potential biases and
chance [5]. According to Rothwell [3], issues that poten-
tially affect external validity can be summarized as set-
ting of the trial, selection of patients, characteristics of
randomized patients, differences between the trial proto-
col and routine practice, outcome measures and follow-
up examinations, as well as adverse effects of treatments
(table 1). In addition, accepted definitions which relate
to how representative a study population is were deter-
mined (e.g., eligibility fraction, enrollment fraction,
recruitment fraction) [6].
The internationally registered INSECT trial was
designed and conducted as a multicenter RCT (mRCT)
comparing two continuous suture techniques with
slowly absorbable monofilament materials (PDS™ or
MonoPlus™)a n do n ei n t e r r u p t e ds u t u r e( V i c r y l ™)f o r
fascial closure after primary elective midline incisions
[1]. The primary endpoint of the INSECT trial was the
occurrence of incisional hernias within one year after
the surgical intervention. The trial was conducted on
625 randomized patients and its primary analysis
showed no differences in the occurrence of incisional
hernias between the three groups after one year.
Further, there were no significant differences with
regard to burst abdomen, wound infection, pulmonary
infections, serious adverse events, and one-year mortal-
ity [1]. The objective of this analysis was to investigate
issues of external validity of the INSECT trial focusing
in particular on institutional and selection biases.
Methods
During the INSECT trial, 625 patients were randomized
at 25 surgical sites between July 11, 2004, and Septem-
ber 26, 2006. The detailed study protocol of the
INSECT trial describes several strategies to ensure high
internal validity including primary hypothesis, randomi-
zation, sample size calculation, harmonization and stan-
dardization of treatment, assessment and bias [1]. In
addition, issues that potentially affect external validity
Table 1 Issues that potentially affect external validity adapted to Rothwell (10).
Heading
Setting of the trial
Healthcare system
Country
Recruitment from primary, secondary, or tertiary care
Selection of participating centers
Selection of participating clinicians
Selection of patients
Eligibility criteria
Exclusion criteria
Random ratio
Patients declining randomization
Characteristics of randomized patients
Baseline clinical characteristics
Severity of disease
Comorbidity
Differences between trial protocol and routine praxis
Trial intervention
Therapeutic or diagnostic advances since the trial was completed
Outcome measures and follow-up
Who measured outcome
Frequency of follow-up
Adequate length of follow-up
Adverse effects of treatment
Completeness of reporting
Selection of trial centers/clinicians
Intensity of trial safety procedures
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the process from screening to randomization in two par-
ticipating centers.
Setting of the trial
The types of all participating surgical departments were
categorized into primary, secondary or tertiary care cen-
ters. Primary care centers (PCC) were defined as hospi-
tals with basic diagnostic and therapeutic options
offering general surgical interventions. Secondary care
centers (SCC) were hospitals with a broader surgical
spectrum (i.e. more specialized departments) and
advanced diagnostic and therapeutic tools to which a
patient had been referred by primary care providers.
Tertiary care centers (TCC) act as referral centers and
are often academic hospitals with the highest standards
of care, including access to most specialists and the
necessary equipment that may be lacking in primary
and secondary care centers. The selection of participat-
ing centers and surgeons was purely based on the self-
motivation of the according centers. Once they agreed
to adhere to the protocol, signed a contract, received
ethical approval from their local ethics committee and
finalized training, they were able to start patient recruit-
ment. In order to assess whether this process caused
imbalances between the patient populations at the dif-
ferent hospital levels, analyses concerning the recruit-
ment of patients and demographics (i.e. age and gender)
as well as clinical parameters (body mass index) and
surgery-related parameters (type of procedures) were
performed. In addition, the level of expertise of surgeons
and the adherence to the protocol were assessed.
Selection of patients
Inclusion and exclusion criteria of the trial were shown
previously [1]. Due to the incomplete recording of
screening lists, the according data was not available
from other participating centers. Patients at the Depart-
ment of Heidelberg were analyzed for demographics
(age and gender), clinical parameters (body mass index,
ASA score, duration of hospitalization, presence of
malignant diseases), and surgery-related parameters
(incision technique, closure technique) according to
three specified subgroups: included patients, eligible
patients who declined participation and eligible patients
randomized to one other RCT.
The random ratio was calculated by dividing the num-
ber of randomized patients/participants by the number
of primarily eligible patients/eligible for participation for
the Department of Surgery of the University of Heidel-
berg and Erlangen. The random ratio thus equals the
enrollment fraction as described by Gross et al. [6].
According to Gross et al. [6] and Jones et al. [7], the
enrollment fraction equals the proportion of people who
are eligible for participation and who actually enroll in
the RCT.
Data analysis was done using SAS™ 9.1 Win (Release
9 . 1 ,S A SI n s t i t u t e ,I n c . ,C a r y ,N C ) .Ad e s c r i p t i o no ft h e
data included absolute and relative frequencies for cate-
gorical data and mean and standard deviations for con-
tinuous data. Possible differences between groups were
calculated with Fisher’s exact test of categorical para-
meters, Kruskal-Wallis test for continuous variables, and
binomial test for proportion of randomized patients.
The explorative statistical significance level was set at
5% (0.05); no adjustment for multiple comparisons was
done due to the descriptive nature of the study.
This article was structured based on the recommenda-
tions according to the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) in
order to include an accurate and complete report of an
observational study [8]. The original INSECT trial was
published in accordance with the CONSORT criteria
[1].
Results
Setting of the trial
The INSECT trial was conducted in Germany. Centers
were recruited on a voluntary basis. Overall, twenty-five
centers enrolled a total of 625 patients between July 11,
2004, and September 26, 2006 (table 2). The distribution
of hospitals according to the three categories was as fol-
lows: 8 PCC, 11 SCC and 6 TCC. TCC enrolled more
patients (n = 237, 37.92%) than PCC (n = 199, 31.84%)
and SCC (n = 189 patients; 30.24%). There were no dif-
ferences in the recruiting of patients between the three
different types of hospitals over time (Figure 1). In order
to test whether the number of randomized patients per
category differed from normal distribution (i.e. the
assumption that each hospital category enrolled one-
third, or 33.3% of all patients), a binomial test was per-
formed. Even though the percentage of randomized
patients to each of the three hospital types (PCC, SCC,
TCC) differed significantly (p < 0.01, Kruskal-Wallis
test, table 2), the observed differences of mean rando-
mized patients per hospital type were not different (p =
0.09, Kruskal-Wallis test, table 2). Significantly more
patients were operated on by head physicians at PCC
compared to SCC and TCC (p < 0.01, Chi-Square test,
Figure 2).
Selection of patients
During the recruitment phase of the INSECT trial, all
patients admitted with a diagnosis requiring a midline
laparotomy were screened to be randomized to the
INSECT trial. After controlling all inclusion and exclu-
sion criteria and receiving informed consent, patients
were included for randomization.
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patients). Analyzing all randomized patients based on
age, gender, and body mass index, there were no differ-
ences between PCC, SCC and TCC. Patients with
tumors located at either the stomach/esophagus or pan-
creas were significantly more often operated on at SCC
and TCC whereas there were no differences in colorec-
tal procedures (table 3). Significantly more patients were
treated according to protocol in PCC and SCC as com-
pared to TCC (table 3). The number of patients lost to
follow-up did not differ significantly between PCC, SCC
and TCC (table 3).
At the Department of Surgery, University of Heidel-
berg, 307 patients scheduled for elective abdominal sur-
gery were screened at admission (24 hours before
surgery) for eligibility from January 13 to August 25,
2005. At the Department of Surgery, University of
Erlangen, 351 patients were screened between October
21, 2004, and February 24, 2006.
The flow chart of patients at both institutions with
corresponding numbers is given in Figure 3. Altogether,
29 out of these 658 patients were excluded because of
new findings during the preoperatively performed diag-
nostic work-up. Out of the remaining 629 patients
(100%), 236 patients (37.5%) were primarily eligible to
participate in the INSECT trial and 393 patients (62.5%)
had to be excluded for not fulfilling all inclusion criteria
or for meeting one or more exclusion criteria. Most of
these patients (n = 230) were excluded because of prior
laparotomy. A further 119 patients who were considered
Table 2 Analysis of participating centers.
Type of care center n Randomized patients (n) Percentage of randomized patients (%)* Mean of randomized patients
(Standard
Deviation)
#
PCC 8 199 31.84 25.0 (12.9)
SCC 11 189 30.24 16.5 (14.0)
TCC 6 237 37.92 39.3 (24.1)
Sum 25 625 100 -
* p < 0.01, Kruskal-Wallis test
# p = 0.09, Kruskal-Wallis test
Type of hospital  PCC  SCC  TCC 
0 
100 
200 
300 
Recruiting time (months) 
0  10  20  30
Patients 
(n) 
Figure 1 Recruiting of 625 patients during the INSECT trial according to PCC, SCC and TCC, respectively.
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related reasons; 69 patients declined randomization; and
33 patients participated in one other RCT [9]. Subse-
quently, a total of 117 patients (18.6% of 629 potential
eligible patients) were randomized into the INSECT trial
resulting in an random ratio (equals enrollment fraction
[6,7] of 49.5% (Heidelberg 46.1%, Erlangen 53.7%).
Based on the given data, the overall eligibility fraction
was 37.5% (Heidelberg 45.1%, Erlangen 31.1%) and the
overall recruitment fraction was 18.6% (Heidelberg
20.8%, Erlangen 16.7%).
0%
20%
40%
60%
80%
100%
PCC
SCC
TCC
Resident 
Fellow 
Attending 
Head Physician
 
 
 
 
 
* Chi-Square test 
* 
Figure 2 Educational status of surgeon who performed the surgical procedures in PCC, SCC and TCC.
Table 3 Baseline characteristics of all randomized patients.
Parameter PCC SCC TCC p-value (Chi-Square)
Age (years)
Mean (SD) 67.7 (10.8) 64.7 (11.5) 61.3 (14.2) n.s.
Gender (n)
female 70 73 86 n.s.
male 118 107 151 n.s.
Body Mass Index (kg/m
2)
Mean (SD) 26.2 (3.7) 25.9 (3.9) 25.6 (3.7) n.s.
Surgical Procedure (n)
vascular 3 3 15 < 0.01
large intestine 106 85 82 n.s.
small intestine 1 0 7 < 0.01
rectum 68 40 37 n.s.
stomach/oesophagus 8 44 28 < 0.01
pancreas 2 2 40 < 0.01
Treatment according to protocol (%)
yes 98.4 97.2 92.4 < 0.01
Lost to follow-up (%)
37.5 38.3 28.7 0.06
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From the 625 randomized patients, there were 210
patients randomized to interrupted suture using an
absorbable braided suture material, 205 patients rando-
mized to continuous suture techniques using PDS™,
and 210 patients randomized to continuous suture tech-
niques using MonoPlus™. All 625 patients were of Cau-
casian origin. After analyzing demographics (age and
gender), clinical parameters (body mass index), and sur-
gery-related parameters (surgical procedures) of all ran-
domized patients, there were no differences between the
three randomized groups (table 3). The indication for
the surgical procedures did not differ between the three
hospital types. In 83% of PCC, 82% of SCC, and 83% of
TCC, the primary diagnosis was associated with the rec-
tum, colon, and stomach/esophagus. Further, the inci-
sion length did not differ significantly between the
randomized groups whereas the closure times for the
continuous groups were significantly shorter compared
to the interrupted group (P < 0.01; [1]).
Surgeons training for standardizing abdominal wall
closure
Midline incision of the abdominal wall is a preferred
strategy to open the abdominal cavity. However, there is
no consent within the surgical community concerning
the optimal abdominal wall closure after midline inci-
s i o n .F o rt h eI N S E C Tt r i a l ,t h et w om o s to f t e nu s e d
methods of abdominal wall closure were compared
using three different suture materials. In order to har-
monize the closure techniques between the different
centers and participating surgeons as much as possible,
all participating centers were trained in how to perform
the different suturing techniques adequately before ran-
domization of the first patient. The results for the three
different hospital categories were excellent with more
than 90% of all patients treated according to protocol.
Outcome measures and follow-up examinations
Patients were observed up to 30 days after the primary
surgical intervention to record adverse and serious
Figure 3 Depiction of the recruitment process at the Departments of Surgery in Heidelberg and Erlangen.
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ondary endpoints (burst abdomen, wound infection, and
postoperative pulmonary complications). The definition
for secondary endpoints is published elsewhere [1]. The
30-day follow-up was conducted by coordinating per-
sonnel. The frequency of incisional hernias was exam-
ined after one year. A surgeon performed the clinical
examination and at minimum an ultrasound of the
abdominal wall had to be performed by a radiologist.
Coordinating personnel as well as surgeons and radiolo-
gists involved in follow-up examinations were blinded to
the method of closing the abdominal wall.
Adverse effects of treatments
During the INSECT trial, adverse events were monitored
and classified by an adverse events committee (AEC)
consisting of three surgeons. All information on adverse
events were initially documented and verified by coordi-
nation personnel and eventually submitted to the AEC.
All adverse events were defined in the published proto-
col [1]. All serious adverse events were reported to the
according regional councils.
Discussion
External validity describes to which extent the results of
RCTs are applicable to patients treated in general prac-
tice. Together with the primary publication [1], the
focus of this analysis was to investigate further aspects
relevant for the external validity of the INSECT trial
mainly according to the issues raised by Rothwell [10].
As the data presented here comprises a significant
amount of new information, it seemed reasonable to
publish this data as a separate article.
Because of prospective data acquisition, external mon-
itoring and external data analysis the INSECT trail is an
optimal source for analyzing external validity. The
INSECT trial was a multicenter German RCT. Thus,
there were no differences based on different healthcare
systems or countries. The participation was voluntarily
suggesting that only motivated surgeons got involved.
Even though the number of participating TCC was the
lowest, the mean number of randomized patients did
not differ between PCC, SCC and TCC, respectively.
One main conclusion of this paper would be that
smaller hospitals such as PCC (or SCC) should be
involved in clinical trials whenever possible because
these hospitals are important resources in terms of
patient recruitment. Not only that, but the here pre-
sented analyses also revealed that the randomization
process occurred at similar speeds in all three types of
hospitals; the adherence to the protocol was significantly
better in PCC and SCC; the number of included patients
and the main characteristics of included patients did not
differ between the three hospital types; and the number
of patients lost to follow-up did not differ significantly
between PCC, SCC and TCC. Thus, the message of the
INSECT trial (i.e. the rate of incisional hernias after
midline incision is not dependent on the used suture
material/technique) is truly independent of the hospital
type in which the patient is operated.
Reasons for not participating in a surgical study are
multifactorial and were not assessed systematically
within this study. However, they include well-known
reasons such as the dislike of randomization procedures,
strict protocols for performance of interventions and
unwillingness for follow-up investigations. In order to
detect potential selection bias, the screening processes
at the Departments of Surgery at the Universities of
Heidelberg and Erlangen were assessed in detail. The
process from screening until randomization could be
described in detail in 116 patients out of 625 rando-
mized patients (18.5%). Even though this alone may not
allow us to draw general conclusions about external
validity, other parameters such as the progress of rando-
mized patients between the different hospitals and the
clinical data of included patients were also similar. This
suggests that the process from screening to randomiza-
tion may be also comparable in all participating centers.
The largest group of excluded patients had a prior
laparotomy. Because this patient group may not benefit
from the results achieved during the INSECT trial,
further studies are needed to define the optimal method
of abdominal wall closure for patients with prior lapar-
otomy. Out of the remaining potentially eligible patients,
another 119 patients had to be excluded because of two
reasons: firstly, patients refused randomization; and sec-
ondly, patients were already included in another RCT,
one of which was the POVATI trial [9].
Compared to the multicenter INSECT trial, the
POVATI trial was conducted as a single center trial at
the Department of Surgery, University of Heidelberg.
Given the inclusion and exclusion criteria, patients with
primary laparotomy were eligible to participate in both
RCTs. The decision by patients to participate in one or
the other study could have an impact on external valid-
ity. Because there were no differences in demographics
and baseline characteristics between patients included in
either trial, it is unlikely that patients enrolled in the
POVATI trial will affect the external validity of the
INSECT trial (table 4). The comparison of the 130
potential eligible patients in Heidelberg revealed signifi-
cant differences only in the applied incision and closure
techniques in non-consenting patients (n = 44) and
patients randomized to the POVATI trial (n = 26). For
non-consenting patients, surgeons could choose freely
their preferred techniques for opening and closing the
abdomen. When given the choice, the vast majority of
surgeons at our hospital chose midline laparotomy as
Fischer et al. BMC Surgery 2012, 12:2
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ing as preferred closure technique. This may suggest
that surgeons at our hospital were somehow biased
towards midline laparotomy and continuous suturing
(table 4).
In general, the random ratio ("enrollment fraction”
according to Gross et al.) describes the proportion of
randomized patients to the primarily eligible patients.
T h er a n d o mr a t i op e rs ed o e sn o ts a ya n y t h i n ga st o
whether the results of a study are widely acceptable. It
is more likely to be a marker of the efforts necessary to
randomize a patient. Even though the random ratio at
the Department of Surgery at the University of Erlangen
was similar to that at the University of Erlangen, the
recruitment period lasted longer in Erlangen (16 months
versus 6 months at Heidelberg). One possible explana-
tion could be that all surgical trainees in Heidelberg
rotate into the clinical study centre and residents who
already finished their rotation are part of an on-call pro-
gram. This setting allows screening and inclusion of
patients even at night or on weekends. In contrast, one
clinical investigator was primarily responsible for patient
recruitment in Erlangen. Considering missing days due
to holidays, weekends, days off after being on call, etc.,
screening and recruiting of patients was only possible
on 120 days.
Table 4 Baseline characteristics of the 60 included patients compared to the 70 patients who had to be excluded due
to non-study related reasons.
Parameter Patients in INSECT trial
(n = 60)
Patients not consenting
(n = 44)
Patients in POVATI trial (n = 26) p-value
Age
Mean (SD) 57.70 (17.08) 55.93 (17.54) 56.69 (12.27) 0.6088*
Gender
female 21 (35.00%) 17 (38.64%) 9 (34.62%)
male 39 (65.00%) 27 (61.36%) 17 (65.38%)
0.9158
#
Body Mass Index
Mean (SD) 25.62 (3.41) 24.61 (3.60) 23.77 (2.51) 0.0786*
ASA score
I 4 (6.67%) 2 (4.55%) 2 (7.69%)
II 34 (56.67%) 27 (61.36%) 15 (57.69%)
III 21 (35.00%) 15 (34.09%) 9 (34.62%)
IV 1 (1.67%) 0 (0.00%) 0 (0.00%)
0.9931
#
Duration of hospitalization
Mean (SD) 14.61 (11.76) 14.34 (11.64) 13.00(6.90) 0.9570*
Malignant disease
none 35 (58.33%) 19 (43.18%) 10 (38.46%)
solid tumors 24 (40.00%) 25 (56.82%) 16 (61.54%)
missing/n.a. 1 (1.67%) 0 (0.00%) 0 (0.00%)
0.1634
#
Incision technique
midline 60 (100.00%) 40 (90.91%) 18 (69.23%)
transverse 0 (0.00%) 3 (6.82%) 8 (30.77%)
laparoscopic 0 (0.00%) 1 (2.27%) 0 (0.00%)
0.0001
#
Closure technique
continuous suture 40 (66.67%) 39 (88.64%) 26 (100.00%)
interrupted suture 20 (33.33%) 4 (9.09%) 0 (0.00%)
missing/n.a. 0 (0.00%) 1 (2.27%) 0 (0.00%)
0.0006
#
* Kruskal-Wallis test,
# Fisher’s exact test
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Most of the criteria for external validity as suggested by
Rothwell [10] have been fulfilled by the INSECT trial.
Abbreviations
INSECT: Interrupted or continuous slowly absorbable suture - Design of a
multi-center randomized trial to evaluate abdominal closure techniques;
PCC: Primary care center; RCT: Randomized controlled trial; SCC: Secondary
care center; TCC: Tertiary care center
Acknowledgements
Supported by BBD-Aesculap, GmbH, Tuttlingen, Germany; Infrastructure of
the SDGC is funded by the German Federal Ministry of Education and
Research (Bundesministerium für Bildung und Forschung (BMBF);
01GH99033) and the German Surgical Society (Deutsche Gesellschaft für
Chirurgie). Additional industrial funding for the infrastructure has been
provided by Johnson & Johnson Medical GmbH, Norderstedt, Germany, and
Covidien Healthcare Deutschland GmbH, Neustadt, Germany. Presented in
part at the 29th Annual Meeting Society of Clinical Trials, St. Louis, USA, May
2008.
The original study on which the present article is based was published 2009
in Annals of Surgery [1].
Author details
1Department of General, Visceral and Transplantation Surgery, University of
Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany.
2Study
Center of the German Surgical Society, University of Heidelberg, Im
Neuenheimer Feld 110, Heidelberg, 69120, Germany.
3Aesculap AG, Am
Aesculap-Platz, Tuttlingen. 78532, Germany.
4Department of Surgery,
University of Erlangen, Krankenhausstrasse 12, Erlangen, 91054, Germany.
5Institute of Medical Biometry and Informatics, University of Heidelberg, Im
Neuenheimer Feld 305, Heidelberg, 69120, Germany.
6Department of General
Surgery, Klinikum rechts der Isar, Ismaninger Straße 22, München, 81675,
Germany.
Authors’ contributions
Study planning: HPK, CMS, MWB, LF, JB, TB; Data collection: HG, LF, HPK, MD,
JB, CMS; Data analysis: TB, MD, CMS, LF; Writing of article: LF, HG, JB; Critical
revision: MWB, CMS, HPK; Final approval: all authors
Competing interests
Hanns-Peter Knaebel is currently working as CEO of Aesculap AG, GmbH,
Tuttlingen, which was one of the sponsors of this study. Other than that
there are no competing interests to state.
Received: 17 May 2011 Accepted: 8 February 2012
Published: 8 February 2012
References
1. Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C,
Franck A, Kieser M, Buchler MW, Knaebel HP: Interrupted or continuous
slowly absorbable sutures for closure of primary elective midline
abdominal incisions: a multicenter randomized trial (INSECT:
ISRCTN24023541). Ann Surg 2009, 249(4):576-582.
2. Hodgson NC, Malthaner RA, Ostbye T: The search for an ideal method of
abdominal fascial closure: a meta-analysis. Ann Surg 2000, 231(3):436-442.
3. Rothwell PM: Factors that can affect the external validity of randomised
controlled trials. PLoS Clin Trials 2006, 1(1):e9.
4. Steg PG, Lopez-Sendon J, Lopez de Sa E, Goodman SG, Gore JM,
Anderson FA, Himbert D, Allegrone J, Van de Werf F: External validity of
clinical trials in acute myocardial infarction. Arch Intern Med 2007,
167(1):68-73.
5. Antes G: [The evidence base of clinical practice guidelines, health
technology assessments and patient information as a basis for clinical
decision-making]. Z Arztl Fortbild Qualitatssich 2004, 98(3):180-184,
discussion 190-182, 214-185.
6. Gross CP, Mallory R, Heiat A, Krumholz HM: Reporting the recruitment
process in clinical trials: who are these patients and how did they get
there? Ann Intern Med 2002, 137(1):10-16.
7. Jones R, Jones RO, McCowan C, Montgomery AA, Fahey T: The external
validity of published randomized controlled trials in primary care. BMC
Fam Pract 2009, 10:5.
8. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC,
Vandenbroucke JP: The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting
observational studies. Lancet 2007, 370(9596):1453-1457.
9. Seiler CM, Deckert A, Diener MK, Knaebel HP, Weigand MA, Victor N,
Buchler MW: Midline versus transverse incision in major abdominal
surgery: a randomized, double-blind equivalence trial (POVATI:
ISRCTN60734227). Ann Surg 2009, 249(6):913-920.
10. Rothwell PM: External validity of randomised controlled trials: “to whom
do the results of this trial apply?”. Lancet 2005, 365(9453):82-93.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2482/12/2/prepub
doi:10.1186/1471-2482-12-2
Cite this article as: Fischer et al.: To whom do the results of the
multicenter, randomized, controlled INSECT trial (ISRCTN 24023541)
apply? - assessment of external validity. BMC Surgery 2012 12:2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fischer et al. BMC Surgery 2012, 12:2
http://www.biomedcentral.com/1471-2482/12/2
Page 9 of 9